Based on this metric, we observed a significant improvement of the HTS performances for both bioassays. Table?3. Overall performances of Ro4 and SVM models for
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor
mTORC1 inhibitor
Based on this metric, we observed a significant improvement of the HTS performances for both bioassays. Table?3. Overall performances of Ro4 and SVM models for